JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baudin-Creuza, V.
Right arrow Articles by Pagnier, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baudin-Creuza, V.
Right arrow Articles by Pagnier, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 36, 25550-25554, September 3, 1999


Additive Effects of beta  Chain Mutations in Low Oxygen Affinity Hemoglobin beta F41Y,K66T*

Véronique Baudin-CreuzaDagger , Corinne Vasseur-Godbillon, Nathalie Griffon, Jean Kister, Laurent Kiger, Claude Poyart, Michael C. Marden, and Josée Pagnier

From INSERM, Unité 473, 84 rue du Général Leclerc, 94276 Le Kremlin-Bicêtre Cedex, France

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In order to decrease significantly the oxygen affinity of human hemoglobin, we have associated the mutation beta F41Y with another point mutation also known to decrease the oxygen affinity of Hb. We have synthesized a recombinant Hb (rHb) with two mutations in the beta  chains: rHb beta F41Y,K66T. In the absence of 2,3-diphosphoglycerate, additive effects of the mutations are evident, since the doubly mutated Hb exhibits a larger decrease in oxygen affinity than for the individual single mutations. In the presence of 2,3-diphosphoglycerate, the second mutation did not significantly increase the P50 value relative to the single mutations. However, the kinetics of CO binding still indicate combined effects on the allosteric equilibrium, as evidenced by more of the slow bimolecular phase characteristic of binding to the deoxy conformation.

Dimer-tetramer equilibrium studies indicate an increase in stability of the mutants relative to rHb A; the double mutant rHb beta F41Y,K66T at pH 7.5 showed a K4,2 value of 0.26 µM. Despite the lower oxygen affinity, the single mutant beta F41Y and double mutant beta F41Y,K66T show only a moderate increase of 20% in the autoxidation rate. These mutations are thus of interest in developing a Hb-based blood substitute.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The search for human hemoglobin (Hb) variants exhibiting a low oxygen affinity without requiring 2,3-diphosphoglycerate (2,3-DPG)1 is of interest in the view of producing a blood substitute. With this objective, we have previously synthesized the recombinant Hb (rHb) beta F41Y using the genetic engineering approach (1). The naturally occurring mutated Hb beta F41Y, first described by Burkert et al. (2), is known as Hb Mequon. The mutation beta F41Y occurs in an important region of the subunit interface, which undergoes large rearrangements in the transition between the deoxy (T state) and the liganded (R state) conformations (3). We have shown that the recombinant Hb beta F41Y exhibits a lower oxygen affinity than Hb A, with a well preserved cooperativity of oxygen binding and without increasing the rate of autoxidation. The decreased oxygen affinity of rHb beta F41Y is attributed mainly to an increase in the allosteric constant, L0 = T0/R0, because the oxygen equilibrium dissociation constants for the T and R states, KT and KR respectively, were not modified (1).

Based on the crystallographic structure of Hb A (4), it appears that there could be an additional hydrogen bond in the deoxy conformation between a tyrosyl residue at the beta 41(C7) site and the carbonyl of the beta 97(FG4) His residue within the same beta  chain. Such an interaction, coupled with the native interchain hydrogen bond between the Tyr-alpha 242(C7) and Asp-beta 199(G1) residues, would help stabilize the deoxy state of rHb beta F41Y.

In addition to the amino acids involved in the alpha 1beta 2 interface, other key residues are important in the cooperative ligand binding to human Hb. Specifically, the amino acids implicated in the heme contact have a crucial role. The study of naturally occurring human mutants has also confirmed the importance of these regions. Indeed, over 600 natural variants of Hb have been described (5), providing information about the role of certain residues in the structural changes between the deoxy and oxy conformations. Among these natural mutants, 54 displayed a decreased oxygen affinity, with 7 and 47 for the alpha  and beta  subunits, respectively. In particular, Hb Chico (beta K66T) with a mutation close to the heme group exhibits a low oxygen affinity and a slight instability (6). In deoxy Hb A, the residue Lys-beta 66 (E10) forms a salt bridge with the carboxyl group of one propionic acid of the beta -chain heme; this contact does not exist in the liganded form (4). X-ray analysis of Hb Chico has shown that Thr-beta 66 may form a hydrogen bond with His-beta 63 via a bridging water molecule. This introduces additional steric hindrance to ligand binding to the T state (7).

With a view to study the combined effects of the mutations F41Y and K66T in the same beta  subunit, we have produced an artificial human Hb beta F41Y,K66T. We report here the functional properties of the double mutant compared with those of native Hb A and the singly mutated Hbs.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The Lys-beta 66 right-arrow Thr mutation was introduced by site-directed mutagenesis into the beta -globin cDNA containing the code for the mutation Phe-beta 41 right-arrow Tyr. The doubly mutated beta  globin was produced as a fusion protein in Escherichia coli using the expression vector pATprTet-cII-FX-beta Gb. After purification and cleavage of the fusion protein by digestion with bovine activated coagulation factor X, the alpha 2beta 2 tetramer was reconstituted in the presence of cyanohemin and native carbonmonoxy alpha  subunits (8, 9). The structure of the mutated chain was checked by reversed-phase high performance liquid chromatography of tryptic digest and amino acid analysis of the two mutated peptides. The purity of the rHb was controlled by isoelectric focusing electrophoresis with a pH gradient ranging from 6.0 to 8.0. The heat stability was tested by incubating rHb beta F41Y,K66T and Hb A (100 µM on a heme basis) at 65 °C in 10 mM phosphate buffer, pH 7.0 (10).

The tetramer-dimer equilibrium was studied by gel filtration on a Superose 12 HR 10/30 column (Amersham Pharmacia Biotech, Uppsala, Sweden) as described by Manning et al. (11). All experiments were performed at 25 °C, in 150 mM Tris acetate buffer, pH 7.5. For concentrations of Hb ranging from 2 to 500 µM on a heme basis, 10-µl aliquots were applied and eluted at a flow rate of 0.4 ml/min. The absorbance of the eluent was measured at 415 and 280 nm. Diaspirin cross-linked (DLC) Hb was used as a control for undissociable tetrameric Hb, and the peak position of the dimer was determined using the dimeric natural mutant Hb Rothschild (12).

The rate of oxidation for liganded Hb samples was measured by absorption spectrophotometry (SLM-Aminco DW2000) at 37 °C for samples under 1 atm of oxygen or under air (13). Hb solutions were 40 µM in heme in 20 mM potassium phosphate at pH 7.0.

Oxygen equilibrium curves were recorded with a continuous method using the Hemox Analyzer system (TCS, Huntington Valley, PA) (14). The amount of metHb calculated from the visible absorption spectra was found to be less than 5% at the end of the recordings.

Fluorescence studies were performed on 10 µM Hb solutions (on a heme basis) in 10 mM phosphate buffer, pH 7.0, using an SLM 8000 spectrofluorometer. Emission spectra were recorded for both the buffer and the liganded Hb samples.

Kinetics of CO or oxygen recombination were obtained after flash photolysis using 10-ns YAG laser pulses (Quantel, France) providing 160 mJ at 532 nm. Samples were in 1-mm cuvettes, with observation at 436 nm (15). Measurements were made at 25 °C, 50 mM bis-Tris at pH 7.0, 100 mM NaCl, for samples equilibrated under air or 1 or 0.1 atm of CO. Kinetics were recorded at different laser energies to probe the Hb tetramer at different ligand saturation levels.

The CO dissociation rate was determined from the kinetics of replacement of CO by NO, with measurements of full spectra versus time using a diode array spectrophotometer (HP 8453).

Kinetics of O2 replacement by CO were measured with a stopped-flow apparatus (Biologic, France) with detection at 420 nm. Experimental conditions were 50 mM bis-Tris at pH 7.0, 100 mM NaCl, at 25 °C. The dead time of this apparatus with a cuvette of 1-cm optical path length is 2 ms. Hb samples equilibrated under 1 atm of oxygen were mixed with a solution equilibrated under 1 atm of CO containing the oxygen scavenger sodium dithionite. The final concentrations after mixing were 5 µM in heme, 5 mM sodium dithionite, 0.6 mM O2, and 0.5 mM CO.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Properties of rHb beta F41Y,K66T-- Analysis of the purified rHb beta F41Y,K66T by isoelectric focusing showed that it migrated as a single band (pI = 6.4), with a more cathodic position relative to Hb A (pI = 6.98). Fluorescence studies did not show significant differences between the doubly mutated rHb and native Hb A; the highly quenched emission indicates a correctly reconstituted (folded) rHb. The UV and visible absorption spectra of rHb beta F41Y,K66T in carboxylated and oxygenated forms were identical to those of native Hb A. Notably, the ratios of absorbance intensity between the Soret band and UV peak at 280 nm were normal, 4.87 and 3.5 for the mutated HbCO and HbO2, respectively. The oxy form of rHb beta F41Y,K66T exhibited the same fraction denaturation as Hb A after a 20-min incubation at 65 °C.

Tetramer-Dimer Equilibrium-- Hb A, rHb A, rHb beta F41Y, and rHb beta F41Y,K66T in the liganded form were eluted as a single peak whose position varied between tetrameric and dimeric forms when the Hb concentrations were in the range of the dissociation constant K4,2 value. The K4,2 value for rHb A was 2-fold higher than that for natural Hb A, in agreement with studies by Fronticelli et al. (16); at high protein concentrations (favoring Hb tetramers), the functional properties of Hb A and rHb A are similar as described previously (17, 18). The K4,2 values for rHb beta F41Y and rHb beta F41Y,K66T were 3- and 6-fold decreased, respectively, compared with that for control rHb A (Table I).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Tetramer-dimer dissociation constants K4,2 for the liganded form of Hb A, rHb A, rHb beta F41Y, and rHb beta F41Y,K66T
The dissociation constants K4,2 were determined by the Hb concentration dependence of peak positions on a Superose-12 HR10/30 column. 10 µl of a Hb solution (2-500 µM on a heme basis) were injected and eluted at a flow rate of 0.4 ml/min. Experiments were performed at 25 °C in Tris acetate buffer, pH 7.5.

Autoxidation-- At 37 °C, the oxidation rate of rHb beta F41Y,K66T under 1 atm of oxygen was increased by 20% compared with that of native Hb A. Under air, the rHb beta F41Y,K66T, which is less oxygen-saturated than Hb A, exhibited a 2-fold increase in oxidation rate relative to Hb A.

Oxygen Equilibrium Curves-- Fig. 1 shows the experimental Hill plots obtained for Hb A, rHb beta F41Y, and rHb beta F41Y,K66T in the absence (Fig. 1A) or in the presence of chloride anions (Fig. 1B). Table II displays the values of the oxygen binding parameters for Hb A, the natural Hb Chico (data of Bonaventura et al. (7)), rHb beta F41Y (1), and the double mutant rHb beta F41Y,K66T in the presence and in the absence of chloride anions.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   Oxygen equilibrium curves for Hb A (1), rHb beta F41Y (2), and rHb beta F41Y,K66T (3) in the absence (A) and in the presence (B) of 100 mM NaCl.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Oxygen binding parameters for Hb A, rHb beta F41Y, Hb Chico, and rHb beta F41Y,K66T
The P50 (mm Hg) and n50 values were calculated by linear regression from the Hill equation for oxygen saturation levels between 40 and 60%. Delta log P50 expresses the shift in P50 for the mutant relative to Hb A. Experimental conditions were as follows: 0.1 M NaCl, 0.05 M bis-Tris or Tris buffer, pH 7.2, 50 µM EDTA, 20 µg/ml catalase, 60-80 µM heme, 25 °C.

In the absence of chloride, the oxygen affinity of the rHb beta F41Y,K66T was decreased 2.5-fold relative to that of control Hb A and by about 1.5-fold relative to that of rHb beta F41Y. The shift in log P50 was 0.34 for Hb Chico, 0.18 for rHb beta F41Y, and 0.42 for the double mutant rHb beta F41Y,K66T, thus showing a partial additivity of the two mutations (Delta log P50 = 0.52 for a maximal additivity effect). The Hill coefficient at half-saturation (n50), an index of oxygen binding cooperativity, was more decreased for rHb beta F41Y,K66T than for rHb beta F41Y.

In the presence of chloride, the double mutant rHb beta F41Y,K66T still exhibited an oxygen affinity lower than Hb A, Hb Chico, and rHb beta F41Y. Nevertheless, the Delta log P50 for rHb beta F41Y,K66T was equal to 0.45 (0.32 in the presence of 2,3-DPG). This indicates that the effects of the two mutations were no longer additive in the presence of effectors. The values of Delta log P50 corresponding to the oxygen-linked heterotropic allosteric effectors showed that the chloride, 2,3-DPG and alkaline Bohr effects were in the normal range of values (Table III).

                              
View this table:
[in this window]
[in a new window]
 
Table III
Heterotropic effects Delta log (P50) in Hb A, rHb beta F41Y, and rHb beta F41Y,K66T
The experimental conditions are described in the legend of Table II.

From the experimental curves (Fig. 1), the allosteric parameters were fitted to the equation of the two-state allosteric model (19) to obtain the oxygen dissociation constants KT and KR for the T and R states, respectively (Table IV).

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Allosteric parameters for Hb A, rHb beta F41Y, and rHb beta F41Y,K66T
The allosteric parameters (L, KR, and KT) were obtained after fitting the experimental curves to the equation of the two-state allosteric model (19) by using a nonlinear least-squares procedure. KR and KT (mm Hg) are the oxygen dissociation constants for the R and T states, respectively; L is the allosteric constant (T0/R0); c = KR/KT; the switchover point is was calculated as -log L/log c; % T3 is the amount of triply liganded T state species calculated as (Lc3)/(1 + Lc3). The standard error per point was typically 0.003-0.006.

In all experimental conditions, the equilibrium curves could be simulated with values of KT and KR for rHb beta F41Y,K66T and rHb beta F41Y, similar to those for Hb A, indicating that the mechanism of the low oxygen affinity was mainly due to the change in the allosteric equilibrium. The allosteric parameter L was higher for rHb beta F41Y,K66T than for Hb A and rHb beta F41Y. The switchover point indicates that the allosteric transition T right-arrow R for rHb beta F41Y,K66T occurs at a higher oxygen saturation level than for Hb A and rHb beta F41Y. The calculated amount of rHb beta F41Y,K66T in the T state for tetramers with three ligands was considerably increased: 85% versus 38 and 16% for rHb beta F41Y and Hb A, respectively. This large increase in the fraction of T state is due to the presence of the mutation beta K66T.

Kinetic Studies-- Fig. 2 shows the recombination traces of CO after photodissociation. For rHb beta F41Y,K66T as for Hb A, the traces were biphasic as expected for tetrameric Hb. At low CO photodissociation levels (5%), the CO recombination kinetics of Hb A were fast and monophasic because in these conditions the majority of the photodissociated tetramers are triliganded and remain in the R state. In the same conditions, the CO recombination kinetics of rHb beta F41Y,K66T still exhibited some slow phase. These results show, as for the oxygen equilibrium curves, that the allosteric equilibrium of partially liganded species of rHb beta F41Y,K66T are displaced toward the T state relative to Hb A. 


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 2.   Kinetics of CO recombination to Hb A and rHb beta F41Y,K66T. Relative to either single mutant, the double mutant shows more of the slow phase, characteristic of CO binding to the deoxy conformation. This demonstrates an additive effect of the two mutations. The addition of inositol hexaphosphate (IHP) provides an additive effect of further increasing the slow fraction as well as a decrease in the rate of the slow phase; while less evident from oxygen equilibrium data, the mutations also show an additive effect with the external effectors.

The oxygen association and dissociation rates for Hb A and rHb beta F41Y,K66T were similar (Table V). These results are consistent with the equilibrium data that show that the value of KR for rHb beta F41Y,K66T was similar to that of Hb A. However, the CO kinetics suggest a change in the R state properties as well as the shift in allosteric equilibrium.

                              
View this table:
[in this window]
[in a new window]
 
Table V
Kinetics of CO and oxygen bimolecular recombination to Hb A and rHb beta F41Y,K66T
Association rates were measured by the flash photolysis method. Oxygen and CO dissociation rates for fully liganded Hb were determined by replacement with CO and NO, respectively. Hb samples were in 50 mM bis-Tris, 100 mM NaCl, 20 °C, pH 7.0.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In order to obtain a modified Hb that could be used as a Hb-based artificial oxygen carrier, we have used two different strategies to decrease the oxygen affinity of human Hb. We first introduced a mutation in the allosteric interface (beta F41Y) to shift the equilibrium toward the T state by inducing an additional hydrogen bond in the T state conformation, without perturbing the R state conformation. To further decrease the oxygen affinity, we have then investigated the association of this mutation with a second substitution known to have a similar effect, but due to another mode of action.

In normal human Hb, the Phe-beta 41 belongs to a cluster of three highly conserved phenylalanine residues, beta 41(C7), beta 42(CD1), and beta 45(CD4), that participate in the formation of the hydrophobic heme pocket; in Hb A, the Phe-beta 41 has contacts with the heme moiety and is critical to the structural integrity and function of the Hb molecule. Decreased oxygen affinity was observed for the naturally mutated Hb Denver Phe-beta 41 right-arrow Ser (20) and Hb Bruxelles deletion of Phe-beta 41 (21). Hb Denver is an unstable Hb variant; the smaller serine residue may impede movement during the allosteric transition of the FG corner of the alpha  subunits along the C helix of the subunits (20). The mutated Hb corresponding to naturally occurring Hb Mequon (2) was synthesized after site-directed mutagenesis to study the functional properties of the pure form (1). The working hypothesis of the beta F41Y mutation was to induce an additional hydrogen bond in the T state conformation without perturbing the R state conformation. If the beta 41 tyrosyl residue forms a new hydrogen bond to the carbonyl of the beta 97 (FG4) histidine residue within the same beta  chain, then the deoxy conformation may be stabilized. While the oxidation rate and heat stability are similar to those of Hb A, this Hb exhibited a 2-fold decrease in oxygen affinity compared with that of Hb A, due to a shift in the allosteric equilibrium.

When two effects have an independent mode of action, the combined effects may be additive. In general, a partial additivity is observed, as shown for the free energy of dimer-tetramer equilibrium for Hb mutants (22). We thus associated the beta F41Y mutation with a substitution of a residue on the distal side of the heme (beta K66T) to directly act on the heme environment. The abnormal Hb Chico, Lys-beta 66 right-arrow Thr, displays a significantly decreased O2 affinity (6, 7). The beta 66 residue is not involved in the subunit interface and is not expected to have a direct effect on the subunit dissociation. x-ray analysis of the deoxy conformation of Hb A shows that Lys-beta 66 makes an ionic bond (salt bridge) between its epsilon  amino group and the carboxyl group of propionate-7 of the heme (4). The disruption of the ionic bond provided by Lys was first suspected to be the cause of the altered O2 binding. Other single amino acid substitutions have been investigated to date by site-directed mutagenic protein engineering, Lys-beta 66 right-arrow Ser and Lys-beta 66 right-arrow Arg, that lead also to decreased O2 oxygen affinity (23), while the natural mutant Hb I-Toulouse, Lys-beta 66 right-arrow Glu (24, 25), and the engineered Hb Lys-beta 66 right-arrow Gly (26) have been reported to have normal oxygen binding function. These substitutions also eliminate the ionic bond; thus, the rupture of the bridge involving the Lys-beta 66 would not be the cause of the low oxygen affinity of Hb Chico. The fact that the monomeric as well as the tetrameric beta  chains of Hb Chico also show a decreased oxygen affinity suggests a tertiary effect (7).

Hb tetramers dissociate reversibly into alpha beta dimers, involving the breaking of certain bonds at the alpha 1beta 2 and alpha 2beta 1 interfaces. The tetramer dissociation constant (K4,2 = [dimer]2/[tetramer]) is on the order of 1 µM for liganded Hb A, while the deoxy (T state) tetramers are much more stable (27). The literature values vary greatly for this parameter. This is in part due to the influence on the solvent conditions; e.g. K4,2 is about 0.2 µM at low ionic force but increases to 1 µM at 100 mM NaCl. Protein folding may also play an important role, since the values reported for rHb are often twice that of native Hb A.

For mutant Hbs, the value of the tetramer dissociation constant may be a useful probe of the stability of the protein (11, 22). In addition to an altered oxygen affinity, Hb Chico Lys-beta 66 right-arrow Thr shows an increase in the fraction dimer and in the autoxidation rate (6, 7). However, we observed a decrease in the K4,2 value for the association of both mutations F41Y and K66T. The K4,2 value for liganded rHb beta F41Y is decreased 3-fold compared with that of rHb A (Table I), and an additional decrease of a factor of 2 was observed for the double mutant.

Quantification of the additivity requires a choice of parameters. The P50 value is one obvious choice for its simplicity and reliability of measurement; however, it depends on several microscopic parameters that determine the intrinsic affinity and allosteric equilibrium. An increase due to the allosteric transition could be compensated by a decrease in KT or an increase in the fraction dimers. In the absence of external effectors, the rHb beta F41Y,K66T exhibits a lower oxygen affinity than for either single mutation; the effects of the mutations are additive. For Hb A, the distance between the residues beta 41 and beta 66 is 15.4 and 17 Å for the T state and R state, respectively. The two residues have no direct contact, as illustrated in Fig. 3, and in principle do not have a correlated participation in their effects on the oxygen affinity. The partial additivity of their effects on the intrinsic oxygen affinity of rHb beta F41Y,K66T is therefore probably due to two independent mechanisms. One can also consider the combined effects of the mutations with the effectors such as 2,3-DPG or inositol hexaphosphate; with 2,3-DPG or inositol hexaphosphate, the additivity is less pronounced (Fig. 2). This does not imply that the two effects are no longer additive but rather that the change in P50 may no longer have the same magnitude. The flash photolysis kinetics are sometimes more sensitive to changes in the allosteric equilibrium for a late switchover point, e.g. when the transition from T to R occurs only after binding the third ligand. Low photodissociation levels can isolate the reaction for binding the fourth ligand.


View larger version (67K):
[in this window]
[in a new window]
 
Fig. 3.   Three-dimensional structure of Hb A in the R state showing the sites Phe-beta 41 (in white) and Lys-beta 66 (in blue). The image was obtained using the VISP program (de Castro and Edelstein, University of Geneva, Switzerland) with a Silicon Graphics 4D25G workstation. The Hb A crystallographic coordinates were taken from the file 1HHO (Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ) for the oxygenated quaternary structure.

The ligand binding properties of this new rHb demonstrate that several mutations may be introduced to obtain combined effects on the oxygen affinity. This would eliminate the need for an external effector, such as 2,3-DPG, as required for a Hb-based blood substitute. However, lower oxygen affinities are often accompanied by an increased autoxidation rate. Unless these parameters can be decoupled, one must accept a compromise of the best oxygen affinity and lowest autoxidation rate (28). The present results show that Hb can be genetically engineered to regulate the oxygen affinity. By associating several smaller changes, the perturbations in the protein stability can be minimized. This appears to be the case for the present study of two mutations in the Hb beta  chains, one inducing a shift in the allosteric equilibrium (beta 41 mutation) and the other inducing a decrease in the intrinsic oxygen affinity (beta 66 mutation). There is no conflict in accommodating both changes, and an overall additive effect is observed.

    ACKNOWLEDGEMENTS

We thank G. Caron, E. Domingues, and V. Jonval for skillful technical assistance. We are grateful to Dr. H. Wajcman for the gift of a sample of Hb Rothschild, and to the Baxter Healthcare Company for DCL Hb.

    FOOTNOTES

* This research was supported by the Institut National de la Santé et de la Recherche Médicale, the Direction de la Recherche et de la Technologie (contract 92/177), and the Faculté de Médecine Paris Sud.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 33-1-46-70-89-89; Fax: 33-1-46-70-64-46; E-mail: baudin@kb.inserm.fr.

    ABBREVIATIONS

The abbreviations used are: 2,3-DPG, 2,3-diphosphoglycerate; rHb, recombinant Hb.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Baudin, V., Pagnier, J., Lacaze, N., Bihoreau, M-T., Kister, J., Marden, M. C., Kiger, L., and Poyart, C. (1992) Biochim. Biophys. Acta 1159, 223-226[CrossRef][Medline] [Order article via Infotrieve]
2. Burkert, L. B., Sharma, V. S., Pisciotta, A. V., Ranney, H. M., and Bruckheimer, S. (1976) Blood 48, 645-651[Abstract/Free Full Text]
3. Perutz, M. F. (1970) Nature 228, 726-739[CrossRef][Medline] [Order article via Infotrieve]
4. Fermi, G., Perutz, M. F., Shaanan, B., and Fourme, R. (1984) J. Mol. Biol. 175, 159-174[CrossRef][Medline] [Order article via Infotrieve]
5. Hardison, R., Chui, D. H. K., Riemer, C., Miller, W., Carver, M., Molchanova, T., Efremov, G., and Huisman, T. H. I. (1998) Hemoglobin 22, 113-127[Medline] [Order article via Infotrieve]
6. Shih, D., Jones, R. T., Shih, M. F. C., Jones, M. B., Koler, R. D., and Howard, J. (1987) Hemoglobin 11, 453-464[Medline] [Order article via Infotrieve]
7. Bonaventura, C., Cashon, R., Bonaventura, J., Perutz, M. F., Fermi, G., and Shih, D. T. (1991) J. Biol. Chem. 266, 23033-23040[Abstract/Free Full Text]
8. Nagai, K., and Thogersen, H. C. (1987) Methods Enzymol. 153, 461-481[Medline] [Order article via Infotrieve]
9. Bihoreau, M. T., Baudin, V., Marden, M., Lacaze, N., Bohn, B., Kister, J., Schaad, O., Dumoulin, A., Edelstein, S. J., Poyart, C., and Pagnier, J. (1992) Protein Sci. 1, 145-150[Abstract]
10. Wajcman, H., Elion, J., and Labie, D. (1973) Nouv. Rev. Fr. Hématol. 13, 89
11. Manning, L. R., Jenkins, W. T., Hess, J. R., Vandegriff, K., Winslow, R. M., and Manning, J. M. (1996) Protein Sci. 5, 775-781[Abstract]
12. Gacon, G., Belkhodja, O., Wajcman, H., and Labie, D. (1977) FEBS Lett. 82, 243-246[CrossRef][Medline] [Order article via Infotrieve]
13. Griffon, N., Baudin, V., Dieryck, W., Dumoulin, A., Pagnier, J., Poyart, C., and Marden, M. C. (1998) Protein Sci. 7, 673-680[Abstract]
14. Kister, J., Poyart, C., and Edelstein, S. J. (1987) J. Biol. Chem. 262, 12085-12091[Abstract/Free Full Text]
15. Marden, M. C., Kister, J., Bohn, B., and Poyart, C. (1988) Biochemistry 27, 1659-1664[CrossRef][Medline] [Order article via Infotrieve]
16. Fronticelli, C., Gattoni, M., Lu, A. L., Brinigar, W. S., Bucci, J. L. G., and Chiancone, E. (1994) Biophys. Chem. 51, 53-57[CrossRef][Medline] [Order article via Infotrieve]
17. Nagai, K., Perutz, M. F., and Poyart, C. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 7252-7255[Abstract/Free Full Text]
18. Kim, H. W., Shen, T. J., Sun, D. P., Ho, N. T., Madrid, M., and Ho, C. (1995) J. Mol. Biol. 248, 867-882[CrossRef][Medline] [Order article via Infotrieve]
19. Monod, J., Wyman, J., and Changeux, J. P. (1965) J. Mol. Biol. 12, 88-118[Medline] [Order article via Infotrieve]
20. Stabler, S. P., Jones, R. T., Head, C., Shih, D. T., and Fairbanks, V. F. (1994) Mayo Clin. Proc. 69, 237-243[Medline] [Order article via Infotrieve]
21. Griffon, N., Badens, C., Lena-Russo, D., Kister, J., Bardakjian, J., Wajcman, H., Marden, M. C., and Poyart, C. (1996) J. Biol. Chem. 271, 25916-25920[Abstract/Free Full Text]
22. Turner, G. J., Galacteros, F., Doyle, M. L., Hedlund, B., Pettigrew, D. W., Turner, B. W., Smith, F. R., Winston, M-P., Rucknagel, D. L., and Ackers, G. K. (1992) Proteins 14, 330-350
23. Kono, M., Miyazaki, G., Nakamura, H., Wada, Y., and Imai, K. (1998) Protein Eng. 11, 199-204[Abstract/Free Full Text]
24. Rosa, J., Labie, D., Wajcman, H., Boigne, J. M., Cabannes, R., Bierme, R., and Ruffie, J. (1969) Nature 223, 190-191[CrossRef][Medline] [Order article via Infotrieve]
25. Labie, D., Rosa, J., Belkhodja, O., and Bierme, R. (1971) Biochim. Biophys. Acta 236, 201-207[Medline] [Order article via Infotrieve]
26. Shih, D. T., Miyazaki, G., and Nagai, K. (1987) Fed. Proc. 46, 1972
27. Thomas, J. O., and Edelstein, S. J. (1973) J. Biol. Chem. 248, 2901-2905[Abstract/Free Full Text]
28. Marden, M. C., Griffon, N., and Poyart, C. (1995) Trans. Clin. Biol. 6, 473-480


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Dewilde, L. Kiger, T. Burmester, T. Hankeln, V. Baudin-Creuza, T. Aerts, M. C. Marden, R. Caubergs, and L. Moens
Biochemical Characterization and Ligand Binding Properties of Neuroglobin, a Novel Member of the Globin Family
J. Biol. Chem., October 12, 2001; 276(42): 38949 - 38955.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baudin-Creuza, V.
Right arrow Articles by Pagnier, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baudin-Creuza, V.
Right arrow Articles by Pagnier, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.